By joining Bio-Techne, you’ll join a company with a powerful and positive purpose of enabling cutting-edge research in Life Sciences and Clinical Diagnostics. Bio-Techne, and all of its brands, provides tools for researchers to further treat and prevent disease worldwide.
Location: Shanghai (or Beijing)
Reports to: Vice President, Asia-Pacific
Mission: Drive Bio-Techne’s leadership in China’s market
Position Overview
Lead the comprehensive commercial strategy for Bio-Techne’s all portfolio across Greater China, focusing on Protein Science, Cell & Gene Therapy (CGT), Spatial Multi-Omics, and Diagnostic Development. Integrate high-value reagents (e.g., ELISA/antibodies/recombinant proteins), precision instruments (e.g., automation platforms, spatial biology systems), and raw materials to establish end-to-end customer value chain. Lead Key Account and Industrial sales teams to deeply engage in strategic accounts’ R&D pipelines, ensuring sustainable growth.
Key Responsibilities (Fit in Bio-Techne business model)
1. Strategic Growth & Portfolio Leadership
Solution Selling: based on the business development needs of Chinese customers, champion integrated platform solutions (e.g., antibody development + automated detection systems, spatial transcriptomics reagents + imaging platforms) targeting leading enterprises and related fast-growing enterprises (ie: CGT companies, CXO and IVD developers).
Emerging Market Capture and Development: Execute Go-to-Market (GTM) strategies for Spatial Biology and Organoid/Cell Therapy segments, establishing KOL-driven lighthouse accounts to further establish business growth engines.
Diagnostics Expansion: Collaborate with Diagnostics Division to support IVD business penetration in local pharma/related diagnostic firms, supporting domestic regulatory needs.
2. Account Management
Strategic Account Ownership:
Guide the KA team to manage Top 30 accounts, addressing customer R&D pain points (e.g., target validation, process QC) with tailored reagent-instrument bundles.
Provide polynomial support (e.g., custom protein development, application training) for key accounts.
3. Cross-Functional Collaboration
R&D and Technical Alignment: Capture China-specific needs for the adaptation of local reagents/instrument (e.g., target-specific antibodies, NMPA-compliant raw materials and instrument) to strengthen the bond between customers and our brand for long term cooperation.
Marketing Synergy:
Lead advanced technical workshops (e.g., protein quantification, spatial single-cell analysis) to strengthen technical branding.
Develop vertical-focused case studies for local market (e.g., CAR-T QC solutions, CDx antibody development), expand our coverage.
Foster collaboration with pre-sales / post-sales team to ensure instrument customer success.
Qualifications (Fit-in Bio-Techne business scenario)
Mandatory Requirements
Experience:
Must have experience in managing direct sales and leading the national sales team across the country.
Must have experience in managing key accounts and major project funnels, being familiar with the top-level personnel of key accounts (the decision-making chain) and is able to maintain good cooperation relationship.
Have a certain level of understanding and in-depth research on certain specialized industries (such as CGT, antibody drugs, CDMO).
Education: BS degree with 10+ years of industry experience is a must.
Quantitative KPI Experiences:
Had led the team to achieve a year-on-year growth of ≥30% for a single product line of high-end scientific research instrument.
Had led the successful signing of platform-level solutions with ≥3 multinational pharmaceutical companies/CXO enterprises (with a single order amount ≥5 million RMB).
Core Competencies (is a plus)
In-depth Technical Understanding:
Ability to interpret experimental data (e.g., WB/IHC results) and propose optimization solutions.
Familiar with the key reagents/instrument requirements in the biopharmaceutical development process (such as cell line screening, process quality control, and release testing).
Preferred Qualifications
Experience commercializing Spatial Biology technologies (Visium, Xenium, MERFISH).
Familiarity with cell therapy QC workflows (viability, vector titer, residual testing).
Native Mandarin fluency + workable English.
Why Join Bio-Techne:
- We offer competitive wages along with extensive benefits for employees and their families.
- We invest in our employees’ financial futures through retirement programs and an employee stock purchase plan.
- We help our employees develop their careers through mentorship, promotional opportunities, training and development, internship programs, and more.
- We offer an international and diverse working environment, enriched by employee resource groups; volunteer and charity events; and employee events that build a culture of caring and belonging.
- We foster a culture of empowerment and innovation, where employees feel valued and encouraged to bring their new ideas to the table.
Bio-Techne is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
To protect the interests of all, Bio-Techne will not accept unsolicited resumes from any source other than a candidate application. Any unsolicited resumes sent to Bio-Techne will be considered Bio-Techne property.
Skills Required
- Master's degree or higher in Life Sciences, Biochemistry, or related field; MBA preferred
- Minimum 15+ years in life science sales leadership with experience in high-value reagents and premium instruments
- Proven IVD raw materials market experience
- Successfully overseen ≥30 regional distributors with conflict-resolution expertise
- Achieved ≥20% YoY growth for premium instrument product lines
- Closed ≥3 enterprise-level solution deals (≥RMB 5M/order) with multinational pharma/CXO firms
- Ability to interpret experimental data (e.g., WB/IHC results) and propose optimization strategies
- Expertise in IVD raw material regulations (NMPA, GMP) and import policies
- Ability to navigate matrixed global-local dynamics
Bio-Techne Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Bio-Techne and has not been reviewed or approved by Bio-Techne.
-
Healthcare Strength — Medical and dental coverage are often regarded as strong, with core health benefits broadly available across U.S. roles. Day-one eligibility and comprehensive options are described as a relative bright spot even when pay sentiment is mixed.
-
Leave & Time Off Breadth — PTO, paid holidays, paid parental leave, and volunteer time are emphasized alongside flexible scheduling. Work-life balance elements are seen as strengths relative to base-pay concerns.
-
Strong & Reliable Incentives — Quarterly or semi-annual bonuses and eligibility for annual cash incentives add meaningful upside for many salaried roles. Structured plans such as a Management Incentive Plan reinforce predictability of variable pay.
Bio-Techne Insights
What We Do
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
